922 related articles for article (PubMed ID: 34911384)
1. Reliability of Inpatient CGM: Comparison to Standard of Care.
Price C; Ditton G; Russell GB; Aloi J
J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients.
Price CE; Fanelli JE; Aloi JA; Anzola SC; Vishneski SR; Saha AK; Woody CC; Segal S
J Clin Anesth; 2023 Aug; 87():111090. PubMed ID: 36913777
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
4. Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.
Spanakis EK; Urrutia A; Galindo RJ; Vellanki P; Migdal AL; Davis G; Fayfman M; Idrees T; Pasquel FJ; Coronado WZ; Albury B; Moreno E; Singh LG; Marcano I; Lizama S; Gothong C; Munir K; Chesney C; Maguire R; Scott WH; Perez-Guzman MC; Cardona S; Peng L; Umpierrez GE
Diabetes Care; 2022 Oct; 45(10):2369-2375. PubMed ID: 35984478
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen.
Galindo RJ; Migdal AL; Davis GM; Urrutia MA; Albury B; Zambrano C; Vellanki P; Pasquel FJ; Fayfman M; Peng L; Umpierrez GE
Diabetes Care; 2020 Nov; 43(11):2730-2735. PubMed ID: 32641372
[TBL] [Abstract][Full Text] [Related]
6. Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen.
Gómez AM; Umpierrez GE; Muñoz OM; Herrera F; Rubio C; Aschner P; Buendia R
J Diabetes Sci Technol; 2015 Aug; 10(2):325-9. PubMed ID: 26330394
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia.
Torres Roldan VD; Urtecho M; Nayfeh T; Firwana M; Muthusamy K; Hasan B; Abd-Rabu R; Maraboto A; Qoubaitary A; Prokop L; Lieb DC; McCall AL; Wang Z; Murad MH
J Clin Endocrinol Metab; 2023 Feb; 108(3):592-603. PubMed ID: 36477885
[TBL] [Abstract][Full Text] [Related]
8. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study.
Sadhu AR; Serrano IA; Xu J; Nisar T; Lucier J; Pandya AR; Patham B
J Diabetes Sci Technol; 2020 Nov; 14(6):1065-1073. PubMed ID: 33063556
[TBL] [Abstract][Full Text] [Related]
9. Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy.
Schaupp L; Donsa K; Neubauer KM; Mader JK; Aberer F; Höll B; Spat S; Augustin T; Beck P; Pieber TR; Plank J
Diabetes Technol Ther; 2015 Sep; 17(9):611-8. PubMed ID: 25927357
[TBL] [Abstract][Full Text] [Related]
10. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.
Kovatchev BP; Patek SD; Ortiz EA; Breton MD
Diabetes Technol Ther; 2015 Mar; 17(3):177-86. PubMed ID: 25436913
[TBL] [Abstract][Full Text] [Related]
11. Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.
Levitt DL; Spanakis EK; Ryan KA; Silver KD
Diabetes Technol Ther; 2018 Jan; 20(1):32-38. PubMed ID: 29293367
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study.
Vellanki P; Cardona S; Galindo RJ; Urrutia MA; Pasquel FJ; Davis GM; Fayfman M; Migdal A; Peng L; Umpierrez GE
Diabetes Care; 2022 Oct; 45(10):2217-2223. PubMed ID: 35675498
[TBL] [Abstract][Full Text] [Related]
13. Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting.
Aloi J; Bode BW; Ullal J; Chidester P; McFarland RS; Bedingfield AE; Mabrey M; Booth R; Mumpower A; Wallia A
J Diabetes Sci Technol; 2017 Jan; 11(1):12-16. PubMed ID: 27555601
[TBL] [Abstract][Full Text] [Related]
14. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
15. Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial.
Davis GM; Hughes MS; Brown SA; Sibayan J; Perez-Guzman MC; Stumpf M; Thompson Z; Basina M; Patel RM; Hester J; Abraham A; Ly TT; Chaney C; Tan M; Hsu L; Kollman C; Beck RW; Lal R; Buckingham B; Pasquel FJ
Diabetes Technol Ther; 2023 Oct; 25(10):677-688. PubMed ID: 37578778
[No Abstract] [Full Text] [Related]
16. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
[TBL] [Abstract][Full Text] [Related]
17. Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study.
Boeder S; Kobayashi E; Ramesh G; Serences B; Kulasa K; Majithia AR
J Diabetes Sci Technol; 2023 May; 17(3):642-648. PubMed ID: 35876258
[TBL] [Abstract][Full Text] [Related]
18. The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes.
Idrees T; Zabala ZE; Moreno EM; Gerges A; Urrutia MA; Ruiz JG; Vaughan C; Vellanki P; Pasquel FJ; Peng L; Umpierrez GE
Diabetes Res Clin Pract; 2023 Apr; 198():110603. PubMed ID: 36871877
[TBL] [Abstract][Full Text] [Related]
19. Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes.
Smiley D; Umpierrez GE; Hermayer K; Newton C; Jacobs S; Olson DE; Khan A; Rizzo M; Peng L; Reyes D; Cardona S; Fonseca V
J Diabetes Complications; 2013; 27(6):637-41. PubMed ID: 23911535
[TBL] [Abstract][Full Text] [Related]
20. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
